Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 7, 2022Kidney MedicineOpen Access

Hemoglobin and Clinical Outcomes in Hemodialysis: An Analysis of US Medicare Data From 2018 to 2020

View Full Paper
Ask AI
Bookmark
Share

Authors

EYEric W. YoungDWDongyu WangAKAlissa Kapke

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Young et al. (2022) studied this question.

synapsesocial.com/papers/6a1dbcbe135e59ca654da5fehttps://doi.org/10.1016/j.xkme.2022.100578
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1History of Erythropoiesis-Stimulating Agents, the Development of Biosimilars, and the Future of Anemia Treatment in Nephrology2017 · 1,150 citations
  2. 2Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease2006 · 2,779 citations
  3. 3The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - the experience of the Lombardy Dialysis Registry1998 · 165 citations
  4. 4Anemia in hemodialysis patients1997 · 246 citations